Resin acids and Rosin acids, aluminum salts

Endpoint summary

Description of key information

The substance is considered to be of low acute oral and dermal toxicity based on experimental data on a low content formulation of this substance and on experimental data on other salts of resin and rosin acids or a soluble aluminium salt.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed

Acute toxicity: via inhalation route

Endpoint conclusion

Endpoint conclusion:

no study available

Acute toxicity: via dermal route

Endpoint conclusion

Endpoint conclusion:

no study available

Additional information

No key acute toxicity data is available for Resin acids and rosin acids, aluminum salts (CAS# 61789-65-9) however, supportive data available from one study on the aluminum resinate and another study on a structural analogue is summarized below. In addition, key and supportive acute toxicity data is available for other members of the category 'Rosins and their salts'.

 

In a supportive acute oral toxicity study similar to OECD 401 (BASF, 1982 RSS), a formulation containing Resin acids and rosin acids, aluminum salts (CAS# 61789-65-9; 9% in formulation) was administered to Tif:RAIf (SPF) rats (5/sex/dose) via oral gavage in a polyethylene glycol vehicle at a dose of 5000 mg/Kg bw formulation (450 mg/Kg bw Al resinate). No mortality was observed through the study period. Transient clinical signs (Sedation, dyspnea, ruffled fur, curved body position) were observed, but the animals recovered within 10 days. Body weight remained unaffected and no compound related gross organ changes were observed. Calculated on the content of the Al resinate, the LD₀ (and LD₅₀) for Resin acids and rosin acids, aluminum salts was determined to be at least greater than 450 mg/Kg bw.

 

In a supportive non-Guideline read across acute oral toxicity study (Hasegawa et al. 1989 RSS), aluminum trichloride (CAS# 7446-70-0) was administered to Wistar rats (10/sex/dose) via oral gavage in water (vehicle) at 6 increasing dose levels. The fifty percent of lethal dose was calculated using the Litchfield and Wilcoxon method. Clinical signs observed included hematuria and blood stool. The LD₅₀ for males was determined to be 3450 mg/Kg bw (95% C.I. = 2900 - 4100 mg/Kg bw) and the LD₅₀ for females was determined to be 3470 mg/Kg bw (95% C.I. = 2630 - 4580 mg/Kg bw).

 

The acute oral (rat) toxicity data for Resin acids and rosin acids, aluminum salts (CAS# 61789-65-9), administered as a 9% formulation in polyethylene glycol, shows that the oral LD₀ (and thus the LD₅₀) is >450 mg/Kg. However, no data is available to inform whether or not the LD₅₀ was >2000 mg/Kg. Therefore, the result of this study does not provide definitive proof that Resin acids and rosin acids, aluminum salts (CAS# 61789-65-9) is not classified for acute toxicity under CLP or GHS. However, for three other salts of Resin acids and rosin acids (K-salt, CAS# 68990-01-2;, Ca/Zn-salt, CAS# 68334-35-0; and Mg-salt, CAS# 68440-56-2), the LD₅₀ was above the limit dose of 2000 mg/Kg bw. No conflicting experimental data on rosin derivatives is known. Therefore, for the resin and rosinates part, the LD₅₀ is predicted to be greater than 2000 mg/Kg bw. No additional hazard is predicted from the Al³⁺ cation, since – if applied in a soluble form (AlCl₃), the LD₅₀ is greater than 2000 mg/Kg bw. As the w/w content of Al³⁺ in the target is 3% versus 20% in AlCl₃, there is an adequate margin of safety for the assessment of the cation.

Results from investigations into the acute toxicity of the category Rosins and their salts are summarised briefly below:

Acute Oral Toxicity

In an early study that pre-dated the development of GLP and study guidelines, treatment of albino rats and guinea pigs with Wood Rosin (Rosin) at doses ranging from 1 -5 g/kg (rats) and 1 -4 g/kg (guinea pigs) resulted in an oral LD50 of 2.8 g/kg in rats and between 1 -2 g/kg in guinea pigs (Kodak Laboratory of Medicine, 1956).

In an acute oral toxicity study, a group of five male and five female rats was administered a single dose of Rosin, reaction products with formaldehyde (CAS No. 91081-53-7) by oral gavage at a dose level of 5000 mg/kg bw (Food & Drug Research Laboratories, Inc, 1985a). The rats were observed for mortality and adverse clinical signs for a period of 15 days. One of five males and two of five females were found dead on the morning following dosing (Day 2). A third female was found dead on Day 3. No other mortality was noted for male or female rats during the study. Abnormal clinical signs were reversible and included decreased activity (1/5 males and 1/5 females), diarrhea (2/5 males and 2/5 females), ataxia (1/5 females), and wet abdomen (2/5 females). No other abnormal clinical signs were evident during the study. All surviving animals of both sexes gained weight over the 15-day observation period. No gross pathological lesions were reported at necropsy. Based on the results of this study, the oral LD50 of Rosin, reaction products with formaldehyde (CAS No. 91081-53-7) is >5000 mg/kg bw in male and female rats.

In another acute oral toxicity study, a group of five male and five female rats was administered a single dose of Rosin, reaction products with formaldehyde (CAS No. 91081-53-7) by oral gavage at a dose level of 1000 mg/kg bw (Food & Drug Research Laboratories, Inc, 1985b). The rats were observed for mortality and adverse clinical signs for a period of 15 days. No mortality was noted during the study. Abnormal clinical signs were limited to diarrhea for a single male and a single female on the day of dosing and on the morning of the day after dosing. No other abnormal clinical signs were evident during the study. All animals of both sexes gained weight over the 15-day observation period. No gross pathological lesions were reported at necropsy. Based on the results of this study, the roal LD50 of Rosin, reaction products with formaldehyde (CAS No. 91081-53-7) is is >1000 mg/kg bw in male and female rats.

The acute oral toxicity of Rosin, oligomers was evaluated in an investigation that pre-dated the development of GLP and study guidelines but which was conducted according to acceptable scientific methodology in effect at the time (Wharf Institute, 1977a). In this study, a group of 10 rats/sex/group received a dose of 2500, 5000, 7500 or 10000 mg/kg bw of the test material administered by oral gavage. All animals in the 2500 mg/kg bw dose group survived to study termination while all females and 8 of 10 males in the high-dose group died. In the 5000 mg/kg bw dose group, 2 of 10 males and 3 of 10 females died.  In the 7500 mg/kg bw dose group, 1 of 10 males and 5 of 10 females died. There were no adverse clinical signs observed during the 14-day observation period and all animals surviving to study termination gained weight. Although a gross post mortem examination was performed on all animals, the results of those examinations were not provided in the study report. The oral LD50 for Rosin, oligomers was between 7500 and 10000 mg/kg bw for males, and between 5000 and 10000 mg/kg bw for females.

The acute oral toxicity of Resin acids and rosin acids, hydrogenated, potassium salts was evaluated in a study conducted according to OECD Guideline 420 (Eastman Kodak Company, 2005a). Following confirmation that a dose of 300 mg/kg bw administered by gavage to a single female rat was not toxic, five female rats were each administered a single dose of 2000 mg/kg bw of the test substance by gavage. All animals survived to study termination. All animals gained weight normally and there were no signs of systemic toxicity. The acute oral LD50 in this study was >2000 mg/kg bw for female rats. 

 

Resin acids and rosin acids, calcium zinc salts was administered to six female rats at a dose level of 2000 mg/kg bw after formulation in olive oil hours (Phycher Bio Developpement, 2010a). At all the observation points up to the termination of the study on day 14, no mortalities, clinical signs or macroscopic abnormalities were observed. The oral LD50 of the test item was greater than the limit dose of 2000 mg/kg bw.

Resin acids and rosin acids, magnesium salts was administered to six female rats at a dose level of 2000 mg/kg bw after formulation in olive oil hours (Phycher Bio Developpement, 2010b).One animal was found dead at 23h 50 min post-dosing. No clinical signs related to the administration of the test substance were observed, except for the single death described above. The oral LD50 of the test item was greater than the limit dose of 2000 mg/kg bw.

 

Acute Dermal Toxicity

In an acute dermal toxicity study, a group of five male and five female rats was administered a single dose of Gum Rosin (Rosin) topically, under a porous gauze dressing, at a dose level of 2000 mg/kg bw in dimethylsulfoxide vehicle for an exposure period of 24 hours (Phycher Bio Developpement, 2009a). Under the conditions of this study, the dermal LD50 of Gum Rosin in male and female Sprague-Dawley rats was > 2000 mg/kg bw. No mortality was observed in the study and, after an absence of body weight gain was noted in all males and females on Day 2, the animals recovered and gained weight normally over the rest of the study period. No systemic clinical signs related to the administration of the test substance were observed. Other than a slight dryness to dryness noted at the treatment site of one or more animals at various times during the study, there were no signs of irritation, necrosis, ulceration or evidence of tissue destruction reported. At necropsy, no gross lesions were observed. Based on the results of this study, Gum Rosin was not acutely toxic to rats via the dermal route.